Drug Trial Radar · NCT03600233
Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors
Last checked: Nov 19, 2026Latest source record: Dec 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
34
Actual
Start
Dec 15, 2018
Primary completion
Sep 30, 2024
Study completion Mar 31, 2026
Sponsor
- Lead sponsor
- TaiRx, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 26, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
CVM-1118 (TRX-818) is a new small molecule chemical entity being developed as a potential anti-cancer therapeutic by TaiRx, Inc. CVM-1118 is a potent anti-cancer agent in numerous human cancer cell lines. The safety of administrating CVM-1118 on human is evaluated from the phase 1 study. The objectives of the phase 2 study is to further investigate the efficacy of CVM-1118 for patients with advanced neuroendocrine tumors.
Conditions
- Neuroendocrine Tumors
- Pancreatic Neuroendocrine Tumor
- Gastro-enteropancreatic Neuroendocrine Tumor
- Lung Neuroendocrine Neoplasm
- Neuroendocrine Carcinoma
Interventions
CVM-1118Drug
Patients will initially receive CVM-1118 orally twice daily at 200 mg per dose (400 mg total daily dose). Patients who tolerate this dose for at least 2 Cycles will have the option of increasing the dose of CVM-1118 to 300 mg BID (600 mg total daily dose) if specific criteria are met.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time-to progression-free survival (PFS)Time frame: 12 months after the last patient enrolled
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Chang Gung Memorial Hospital, KaoHsiung
Kaohsiung City, Taiwan
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan
New Taipei Municipal TuCheng Hospital
New Taipei City, Taiwan
China Medical University Hospital
Taichung, Taiwan
Taichung Veterans General Hospital
Taichung, Taiwan
National Cheng Kung University Hospital
Tainan, Taiwan
Taipei Veterans General Hospital
Taipei, Taiwan
Chang Gung Memorial Hospital, LinKou
Taoyuan City, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.